NCT07200518

Effect of Probiotics After Neurosurgery

The Multistrain Probiotic OMNi-BiOTiC® Hetox for Treatment After Neurosurgery (ProSURG)

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 110 (estimated)
• Sponsor: University Maribor · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The goal of this randomised controlled trial is to determine the effect of consuming a multistrain probiotic OMNi-BiOTiC® Hetox on improving the healing, pain management, and postsurgical complications after neurosurgery. The main question it aims to answer is: • Is the multistrain probiotic OMNi-BiOTiC® Hetox effective in in improving patient-reported disability after neurosurgery? Researchers will compare the probiotic group and the placebo group to determine if the healing is significantly different between the groups.

Conditions

• Healing

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	OMNi-BiOTiC® Hetox multistrain probiotic	OMNi-BiOTiC® Hetox multistrain probiotic
DIETARY_SUPPLEMENT	Placebo	Placebo

Timeline

• Start date: 2025-11-03
• Primary completion: 2026-12-31
• Completion: 2027-06-01
• First posted: 2025-10-01
• Last updated: 2025-11-28

Locations

1 site across 1 country: Slovenia